First-in-Human Study of the Pharmacokinetics and Antiviral Activity of IDX375, a Novel Nonnucleoside Hepatitis C Virus Polymerase Inhibitor

類似資料

• Single-Dose Escalation and Multiple-Dose Safety, Tolerability, and Pharmacokinetics of IDX899, a Candidate Human Immunodeficiency Virus Type 1 Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Subjects
  著者:: Zhou, Xiao-Jian, 等
  出版事項: (2009)
• Safety and Pharmacokinetics of IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor of Hepatitis C Virus, in Healthy Subjects
  著者:: Zhou, Xiao-Jian, 等
  出版事項: (2011)
• Short-Term Monotherapy with IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor, in Patients with Chronic Hepatitis C Virus Infection
  著者:: Lalezari, Jacob, 等
  出版事項: (2012)
• Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase Inhibitor
  著者:: Lai, Ming-Tain, 等
  出版事項: (2009)
• Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor
  著者:: Ferris, Robert G., 等
  出版事項: (2005)